Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Linezolid Exposure Is Associated with Cytopenias in Patients Treated for Multidrug-Resistant Tuberculosis.
Graciaa DS, Kipiani M, Magee MJ, Mikiashvili L, Barbakadze K, Bablishvili N, Auld SC, Alghamdi WA, Alshaer MH, Peloquin CA, Avaliani Z, Blumberg HM, Kempker RR. Graciaa DS, et al. Among authors: alshaer mh. Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0040822. doi: 10.1128/aac.00408-22. Epub 2022 Aug 2. Antimicrob Agents Chemother. 2022. PMID: 35916515 Free PMC article.
Why is the Implementation of Beta-Lactam Therapeutic Drug Monitoring for the Critically Ill Falling Short? A Multicenter Mixed-Methods Study.
Barreto EF, Chitre PN, Pine KH, Shepel KK, Rule AD, Alshaer MH, Abdul Aziz MH, Roberts JA, Scheetz MH, Ausman SE, Moreland-Head LN, Rivera CG, Jannetto PJ, Mara KC, Boehmer KR. Barreto EF, et al. Among authors: alshaer mh. Ther Drug Monit. 2023 Aug 1;45(4):508-518. doi: 10.1097/FTD.0000000000001059. Epub 2023 Mar 21. Ther Drug Monit. 2023. PMID: 37076424 Free PMC article.
Protein Binding of First-Line Antituberculosis Drugs.
Alghamdi WA, Al-Shaer MH, Peloquin CA. Alghamdi WA, et al. Antimicrob Agents Chemother. 2018 Jun 26;62(7):e00641-18. doi: 10.1128/AAC.00641-18. Print 2018 Jul. Antimicrob Agents Chemother. 2018. PMID: 29735566 Free PMC article.
Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis.
Lange C, Alghamdi WA, Al-Shaer MH, Brighenti S, Diacon AH, DiNardo AR, Grobbel HP, Gröschel MI, von Groote-Bidlingmaier F, Hauptmann M, Heyckendorf J, Köhler N, Kohl TA, Merker M, Niemann S, Peloquin CA, Reimann M, Schaible UE, Schaub D, Schleusener V, Thye T, Schön T. Lange C, et al. J Intern Med. 2018 May 28. doi: 10.1111/joim.12780. Online ahead of print. J Intern Med. 2018. PMID: 29806961 Free article.
Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis.
Alghamdi WA, Alsultan A, Al-Shaer MH, An G, Ahmed S, Alkabab Y, Banu S, Barbakadze K, Houpt E, Kipiani M, Mikiashvili L, Schmidt S, Heysell SK, Kempker RR, Cegielski JP, Peloquin CA. Alghamdi WA, et al. Antimicrob Agents Chemother. 2019 Apr 25;63(5):e00055-19. doi: 10.1128/AAC.00055-19. Print 2019 May. Antimicrob Agents Chemother. 2019. PMID: 30858211 Free PMC article.
Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection.
Al-Shaer MH, Alghamdi WA, Alsultan A, An G, Ahmed S, Alkabab Y, Banu S, Barbakadze K, Houpt E, Kipiani M, Mikiashvili L, Cegielski JP, Kempker RR, Heysell SK, Peloquin CA. Al-Shaer MH, et al. Antimicrob Agents Chemother. 2019 Jun 24;63(7):e00279-19. doi: 10.1128/AAC.00279-19. Print 2019 Jul. Antimicrob Agents Chemother. 2019. PMID: 31061152 Free PMC article.
77 results